PUBLISHER: The Business Research Company | PRODUCT CODE: 1942818
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942818
Endovascular stent grafts are medical devices used to treat blood vessel problems such as aneurysms or narrowing. They consist of a metal mesh tube covered with a fabric graft and are inserted into the affected vessel through a catheter, usually via a large artery in the groin or arm. These devices repair damaged or weakened vessels and offer a less invasive alternative to open surgery.
The main product categories of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Hemodialysis access grafts are specialized vascular grafts designed to create access for hemodialysis in patients with renal failure. The raw materials include synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts, which are used in applications such as cardiac aneurysms, kidney failure, vascular occlusions, and coronary artery diseases.
Tariffs are impacting the endovascular stent graft market by increasing costs of imported stent materials, including metal alloys and biologic graft fabrics. Segments like thoracic and abdominal endovascular stent grafts are most impacted, particularly in Asia-Pacific regions such as China and India, which are major production and import hubs. The resulting higher costs and potential supply chain delays have prompted manufacturers to explore local sourcing and production. Positively, tariffs have encouraged investment in domestic manufacturing capabilities and innovation in cost-efficient stent graft solutions.
The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with a endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.45 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, increasing awareness of aortic aneurysm treatments.
The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to technological innovations in endovascular stent grafts, rising minimally invasive surgeries, growth in aortic aneurysm and dissection cases, increasing adoption of hybrid vascular grafts, expansion of cardiovascular healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for customized stent grafts, advancements in hybrid and biologic graft materials, expansion of thoracic and abdominal aortic repair procedures, enhanced focus on patient safety and regulatory compliance.
The increasing prevalence of cardiovascular diseases is increasingly supporting the expansion of the endovascular stent graft market going forward. Cardiovascular disease refers to a broad category of conditions involving the heart or blood vessels. The rising prevalence of cardiovascular diseases is influenced by lifestyle behaviors, pre-existing medical conditions, genetic predispositions, and environmental factors. Endovascular stent grafts provide an effective treatment option by reinforcing weakened blood vessel walls, reducing rupture risk, and minimizing invasive surgical intervention while improving patient outcomes. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging approximately 156 cases per day. As a result, the growing prevalence of cardiovascular diseases is strengthening demand within the endovascular stent graft market.
Leading companies operating in the endovascular stent grafts market are focused on developing innovative products such as thoracic aortic stent grafts to improve treatment precision, enhance patient outcomes, and address complex anatomical challenges. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta by providing a safe and effective minimally invasive treatment option. For example, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its first clinical application in Switzerland. The system's multi-branch design allows treatment of complex thoracic aortic conditions while preserving blood flow to critical arterial branches.
In December 2023, TekniPlex Healthcare Inc., a US-based provider of medical device components, acquired Seisa Medical S.A. de C.V. for an undisclosed amount. Through this acquisition, TekniPlex aims to expand its medical device manufacturing capabilities and strengthen its presence in the Latin American healthcare market. Seisa Medical S.A. de C.V. is a Mexico-based manufacturer specializing in endovascular stent grafts.
Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.
North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endovascular Stent Grafts Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.